BioMatrix Specialty Pharmacy Selected As Authorized Provider Of Vonvendi


BIOMATRIX SPECIALTY PHARMACY SELECTED AS AUTHORIZED PROVIDER OF VONVENDI

Agreement Enhances BioMatrix Product Offering to VWD Community

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

FOR IMMEDIATE RELEASE
[DOWNLOAD PDF]

Weston, FL – May 2, 2018 – BioMatrix Specialty Pharmacy announced today their selection as an authorized provider of Shire’s limited distribution drug, Vonvendi™ [von Willebrand factor (Recombinant)]. Vonvendi is the first recombinant product indicated for on-demand treatment and control of bleeding episodes in adults diagnosed with von Willebrand disease (VWD). Von Willebrand disease is the most common bleeding disorder, affecting up to 1% of the US population. The chronic condition is caused by missing or dysfunctional von Willebrand Factor (VWF), leading to frequent recurring bleeding episodes.

Vonvendi is infused intravenously to replace missing or dysfunctional VWF. It is the first product to offer recombinant von Willebrand factor (rVWF) independent of recombinant Factor VIII (rFVIII). Shire reports this allows for a more tailored, patient specific treatment approach. Phase 3 open-label clinical study data demonstrated 100% treatment success using Vonvendi to control bleeding episodes.

“As a specialty pharmacy with extensive experience helping people with bleeding disorders effectively manage their condition, we are pleased to partner with Shire to offer Vonvendi,” said BioMatrix Chief Clinical Officer Marc Stranz. “We are committed to connecting patients with the products, resources and support to live a healthier life.”

To refer your patients to BioMatrix for Vonvendi therapy, please contact the pharmacy directly at 877-337-3002, online, or by completing a patient referral form. To review prescribing and other Vonvendi product information visit http://www.vonvendi.com.  

About BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions including bleeding disorders, solid organ transplants, hepatitis C, HIV and more.  Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life.  The current BioMatrix family of companies includes BiologicTx, Decillion Healthcare, Elwyn Pharmacy Group, Factor Support NetworkMatrix Health, and Medex Biocare.

BioMatrix Specialty Pharmacy Acquires Decillion Healthcare Extending Footprint In Midwestern States


BIOMATRIX SPECIALTY PHARMACY ACQUIRES DECILLION HEALTHCARE EXTENDING FOOTPRINT IN MIDWESTERN STATES

Second Acquisition Expands BioMatrix Therapeutic Expertise And Limited Distribution Access

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

DECILLION_BMX_LOGO.jpg

FOR IMMEDIATE RELEASE
[DOWNLOAD PDF]

Weston, FL – April 2, 2018 BioMatrix Specialty Pharmacy announced that it has acquired Decillion Healthcare, near Columbus, Ohio effective March 13, 2018.  Decillion provides individualized pharmacy and clinical support services for patients with chronic, difficult to treat conditions in neurology, oncology, gastroenterology, immunology, rheumatology and more. Decillion also provides infusion services from their wholly-owned ambulatory infusion center in Dublin, Ohio. The pharmacy is accredited by the Joint Commission and is a member organization of the NHIA Standards for Ethical Practice.

Resulting from the acquisition, BioMatrix enhances its capabilities in neurology, oncology and limited distribution drugs, while also establishing a bricks and mortar location in Ohio. The acquisition expands the BioMatrix footprint to twelve (12) specialty pharmacy locations nationwide, serving over 1,700 patients across a range of therapeutic categories.

“Decillion’s commitment to individualized patient care makes them a great addition to the BioMatrix family of companies,” said Bruce Greenberg, CEO at BioMatrix. “We are excited to expand our services further in the neurology, oncology and limited distribution drug categories, bringing our proven model of care to patients who need it the most.” 

“We are extremely excited to join BioMatrix,” stated Kenneth Ford, Owner and Chief Strategy Officer, Decillion Healthcare. “Our combined experience and dedication to individualized service will bring synergies allowing us to affect positive outcomes for the patients and communities we serve.”

About BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions including bleeding disorders, solid organ transplants, hepatitis C, HIV and more.  Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life.  The current BioMatrix family of companies includes BiologicTx, Elwyn Pharmacy Group, Factor Support Network, Matrix Health, and Medex Biocare

Factor Support Network Earns Perfect Score In Urac Specialty Pharmacy Accreditation


FACTOR SUPPORT NETWORK EARNS PERFECT SCORE IN URAC SPECIALTY PHARMACY ACCREDITATION

Second Member Of The BioMatrix Family Of Companies To Receive Perfect URAC Score Within Last 12 Months

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

FOR IMMEDIATE RELEASE
[DOWNLOAD PDF]

Weston, FL – March 26, 2018Factor Support Network, a member of the BioMatrix family of companies, proudly announced today that it has received a 100% URAC Application Score with zero deficiencies for specialty pharmacy at its Camarillo, CA location.  This reaccreditation marks the third perfect URAC assessment score for a BioMatrix company, and the second within the last 12 months.  URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation.  Through reaccreditation, Factor Support Network has demonstrated a commitment to quality services, clinical expertise, and unsurpassed patient care.

“As a BioMatrix company, Factor Support Network is committed to providing pharmacy and support services helping patients achieve better health. URAC accreditation validates this commitment and represents our dedication to meeting and exceeding industry standards,” stated Bruce Greenberg, CEO at BioMatrix. "We applaud Factor Support Network on their achievement." 

“It’s necessary for specialty pharmacies to provide a higher level of treatment for patients so desired outcomes are achieved.  Factor Support Network shows a dedication to patient education and safety through the recognition of quality it received with URAC’s independent accreditation,” said URAC President and CEO Kylanne Green.  “With URAC accreditation, people know that Factor Support Network strives to adhere to industry best practices.”

About Factor Support Network
Factor Support Network, a member of the BioMatrix family of companies, was founded in 1994 by families who were affected with chronic healthcare challenges with the goal to meet the diverse needs of families and persons facing lifelong illnesses such as hemophilia and von Willebrand Disease.  We are committed to providing individualized, patient-focused services to people with bleeding disorders and other chronic conditions, nationwide.   Our services promote better health through encouraging positive self-management and building a local network of support.

About BioMatrix SpRx
BioMatrix SpRx offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions including bleeding disorders, solid organ transplants, hepatitis C, HIV and more.  Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life.  The current BioMatrix family of companies includes BiologicTx, Elwyn Pharmacy Group, Factor Support Network, Matrix Health, and Medex Biocare

About URAC
Founded in 1990, URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation.  URAC is a nonprofit organization using evidence-based measures and developing standards through inclusive engagement with a range of stakeholders committed to improving the quality of healthcare.  Our portfolio of accreditation and certification programs span the healthcare industry, addressing healthcare management, healthcare operations, health plans, pharmacies, telehealth providers, physician practices, and more.  URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.

BioMatrix SpRx Selected as Authorized Provider of Hemlibra


BIOMATRIX SPRX SELECTED AS AUTHORIZED PROVIDER OF HEMLIBRA

First New Product for Hemophilia Inhibitor Patients in Nearly 20 Years

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

FOR IMMEDIATE RELEASE
[DOWNLOAD PDF]

Weston, FL – December 14, 2017 – BioMatrix SpRx today announced they have been selected as an authorized specialty pharmacy provider of Genentech’s new drug, Hemlibra (emicizumab-kxwh). The product is indicated for pediatric and adult patients who have hemophilia A with inhibitors.

Receiving Breakthrough Therapy Designation by the FDA in 2015, Hemlibra is the first self-administered, subcutaneous therapy for hemophilia. Data from ongoing clinical studies indicates once weekly injections substantially reduce bleed rates. To review information regarding Hemlibra, including the full list of authorized providers, visit the Genentech Hemlibra webpage. www.hemlibra.com  

Chief Clinical Officer David McCormick shares, “We are thrilled to partner with Genentech to offer Hemlibra. We have a long history of supporting patients with inhibitors and understand the unique challenges this community faces. We have witnessed the quality of life improvements this drug can provide, and are so proud to play our role in helping patients experience better health.”

To refer your patients to BioMatrix for Hemlibra therapy, please contact the pharmacy directly at 877-337-3002, online, or by completing a patient referral form.  

About BioMatrix SpRx
BioMatrix SpRx, a portfolio company of Acon Investments and Triton Pacific Capital Partners, LLC., offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions.  Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life.  The current BioMatrix family of companies includes Matrix Health Group, Factor Support Network, Medex BioCare, BiologicTx, and Elwyn Pharmacy Group.

BioMatrix Family of Companies Expands with Acquisition of Elwyn Pharmacy Group


Purchase Doubles Company Size And Adds Therapeutic Categories To Portfolio Of Services

Weston, FL – November 8, 2017BioMatrix SpRx, a growing leader in the specialty pharmacy industry, today announced the acquisition of Elwyn Pharmacy Group in Garnet Valley, Pennsylvania, 30 miles southwest of Philadelphia.

BioMatrix offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions. The growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. BioMatrix excels in providing services for hemophilia and bleeding disorders, transplant therapy, IVIg and specialty care, and digital health technology.

Elwyn Pharmacy Group provides medications and supportive services for patients living with hard to treat disease states with the goal of achieving optimal patient outcomes. This is realized through compliance and individualized therapy management in an environment that maximizes patient satisfaction and adherence. Elwyn’s expertise in neurological and auto-immune disorders, fertility, oncology, and other chronic conditions has made them a leader in the specialty pharmacy industry.

As a result of this transaction, BioMatrix has expanded their services into complementary therapeutic categories requiring the same high-touch services they are accustomed to providing. BioMatrix’s national footprint increases to 11 pharmacy locations, nationwide, in key metropolitan locations. Elwyn joins the rapidly growing family of companies that comprise

BioMatrix including Matrix Health Group, Factor Support Network, Medex BioCare, and BiologicTx.

“The acquisition of Elwyn Pharmacy Group complements our strategy of bringing together leaders in the specialty pharmacy industry to provide comprehensive, compassionate care to patients living with complex, chronic diseases, “stated Bruce Greenberg, Chief Executive Officer, BioMatrix SpRx. “We are pleased to welcome Elwyn and their experienced staff to the BioMatrix family.”

“BioMatrix and Elwyn share very similar values. The success of both companies is rooted in our collaborative, compassionate patient-centered approach,” stated Nicholas Karalis, Chief Executive Officer, Elwyn Pharmacy Group. “Together, we expand our ability to provide a high level of individualized, focused care to patients living with a chronic condition. We are extremely excited to be part of this larger organization.”

Additional information on BioMatrix and Elwyn can be found at www.biomatrixsprx.com and www.elwynspecialtycare.com, respectively.

About BioMatrix SpRx

BioMatrix SpRx, a portfolio company of Acon Investments and Triton Pacific Capital Partners, LLC., offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions. Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. The current BioMatrix family of companies includes Matrix Health Group, Factor Support Network, Medex BioCare, BiologicTx.

About Elwyn Pharmacy Group

Elwyn Pharmacy Group provides a complete range of specialty pharmacy and infusion services. We treat a wide array of complex disease states such as Multiple Sclerosis, Hepatitis C and other GI related diseases, Oncology/Cancer, bleeding disorders, Rheumatoid Arthritis, Psoriasis and HIV. The Elwyn Pharmacy Group includes Elwyn Pharmacy, Glen Rock Medical Pharmacy, Elwyn Specialty Care, and Med Center Specialty Pharmacy.